SHIRE HUMAN GENETIC THERAPIES, INC. sold 3.0% of their position (213.87K shares) of TRANSLATE BIO, INC. on the open market
Open‑market sale worth $4.24M — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 4 sales
Filed: 6/3/2020ACC: 0001395064-20-000082
10% Owner
Since Jul 2018
-213.87K
Net shares
Net seller
$4.24M
Total sold
4
Open market trades
0B · 4S
4
Total transactions
213.87K disposed
Non-Derivative Transactions4
Common Stock
Direct
Shares
−107.07K
Price / share
$19.85
Trade value
$2.13M
% of position
1.5%
6/1/2020
7.08M→6.97M
Common Stock
Direct
Shares
−1.40K
Price / share
$20.53
Trade value
$28.74K
% of position
0.0%
6/1/2020
6.97M→6.97M
Common Stock
Direct
Shares
−100.39K
Price / share
$19.75
Trade value
$1.98M
% of position
1.4%
6/2/2020
6.97M→6.87M
Common Stock
Direct
Shares
−5.01K
Price / share
$20.02
Trade value
$100.22K
% of position
0.1%
6/2/2020
6.87M→6.87M
Total
Net shares
−213.87K
Net value
-$4.24M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/1/2020 | S · Sale | −107.07K | $19.85 | $2.13M | 1.5% | 7.08M | 6.97M |
| Common Stock Direct | 6/1/2020 | S · Sale | −1.40K | $20.53 | $28.74K | 0.0% | 6.97M | 6.97M |
| Common Stock Direct | 6/2/2020 | S · Sale | −100.39K | $19.75 | $1.98M | 1.4% | 6.97M | 6.87M |
| Common Stock Direct | 6/2/2020 | S · Sale | −5.01K | $20.02 | $100.22K | 0.1% | 6.87M | 6.87M |
| Total | −213.87K | -$4.24M | ||||||
Derivative Transactions0
No derivative transactions reported